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A b s t r a c t
Introduction: Contrast medium Pd/Pa ratio (cFFR) was introduced as an alternative to fractional flow reserve (FFR).
Aim: To assess the accuracy of cFFR in predicting of FFR, quantitative flow ratio (QFR) and instantaneous wave-free ratio (iFR).
Material and methods: Resting Pd/Pa, cFFR, FFR, QFR, and iFR were measured in 110 intermediate coronary lesions. cFFR was 
obtained after intracoronary injection of contrast medium. FFR was measured after the intravenous administration of adenosine. 
QFR was derived from fixed empiric hyperemic flow velocity based on coronary angiography. iFR was calculated by measuring the 
resting pressure gradient across a coronary lesion during diastole.
Results: Forty-four patients with 110 intermediate coronary lesions were enrolled. Mean baseline Pd/Pa was 0.93 ±0.05. Mean 
cFFR value was similar to FFR value (0.83 ±0.09 vs. 0.81 ±0.09; p = 0.13) and QFR (0.81 ±0.1; p = 0.69) and iFR (0.90 ±0.07; p = 
0.1). A total of 46 vessels (41.8%) had FFR ≤ 0.80, 50 (45.5%) vessels had cFFR ≤ 0.83, 44 (40.0%) vessels had QFR ≤ 0.80, and 
38 (34.5%) vessels had iFR ≤ 0.89. An excellent agreement between cFFR and resting Pd/Pa, FFR, QFR, and iFR was confirmed (in-
traclass correlation coefficients of 0.83, 0.99, 0.98, and 0.88, respectively). The optimal cutoff value of cFFR was 0.83 for prediction 
of FFR ≤ 0.80 with sensitivity, specificity, and accuracy of 96.9%, 97.8%, and 97.3%, respectively. 100% sensitivity was observed for 
a cutoff value of 0.82 and 100% specificity for a cutoff value of 0.84; AUC = 0.998 (0.995–1.00); p < 0.001.
Conclusions: Contrast medium Pd/Pa ratio seems to be accurate in predicting the functional significance of borderline coronary 
lesions assessed with FFR, iFR, and QFR.
Key words: coronary artery disease, fractional flow reserve, quantitative flow ratio, instantaneous wave free ratio, Pd/Pa.
S u m m a r y
Resting Pd/Pa, contrast medium Pd/Pa ratio (cFFR), fractional flow reserve (FFR), quantitative flow ratio (QFR), and instan-
taneous wave-free ratio (iFR) were measured in 110 intermediate coronary lesions. Mean baseline Pd/Pa was 0.93 ±0.05. Mean 
cFFR value was similar to FFR value (0.83 ±0.09 vs. 0.81 ±0.09; p = 0.13) and QFR (0.81 ±0.1; p = 0.69) and iFR (0.90 ±0.07; p = 0.1). 
A total of 46 (41.8%) vessels had FFR ≤ 0.80, 50 (45.5%) vessels had cFFR ≤ 0.83, 44 (40.0%) vessels had QFR ≤ 0.80, and 
38 (34.5%) vessels had iFR ≤ 0.89. An excellent agreement between cFFR and resting Pd/Pa, FFR, QFR, and iFR was confirmed 
(intraclass correlation coefficients of 0.83, 0.99, 0.98, and 0.88, respectively). The optimal cutoff value of cFFR was 0.83 for 
prediction of FFR ≤ 0.80 with sensitivity, specificity, and accuracy of 96.9%, 97.8%, and 97.3%, respectively. 100% sensitivity 
was observed for a cutoff value of 0.82 and 100% specificity for a cutoff value of 0.84; AUC = 0.998 (0.995–1.00); p < 0.001.
Introduction
Fractional flow reserve (FFR) obtained after the 
achievement of pharmacologically induced maximal 
hyperemia has been demonstrated not only as a  gold 
standard for the assessment for intermediate coronary 
stenosis severity in the cathlab but also as a parameter 
improving prognosis in terms of revascularization with 
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a fixed cut-off value of 0.8 [1–6]. Recent data confirmed 
the non-inferiority of instantaneous wave-free ratio (iFR) 
to FFR in terms of lesion severity assessment along with 
long-term clinical outcomes [7, 8]. Quantitative flow ra-
tio (QFR) assessment, on the other hand, involves an ad-
vanced algorithm that enables fast computation of pres-
sure decreases in intermediate coronary artery disease 
(CAD) without any invasive physiologic measurements or 
pharmacologic hyperemia induction, and its diagnostic 
performance has already been confirmed [9, 10]. Radio-
graphic contrast medium, routinely used during coronary 
angiography, has been demonstrated to induce hyper-
emia, e.g. during the check of pressure wire placement 
[11]. Pd/Pa ratio registered by pressure wire during sub-
maximal reactive hyperemia induced by intracoronary 
injection of contrast medium may be sufficient for the 
assessment of the physiological severity of stenosis in 
a  large number of cases, avoiding the need of adenos-
ine administration. The CONTRAST study, comparing the 
ability of contrast medium Pd/Pa ratio (cFFR) to predict 
FFR versus resting indices, showed that cFFR was superi-
or to resting Pd/Pa and iFR for predicting FFR while rest-
ing Pd/Pa and iFR provided equivalent diagnostic accu-
racy [12]. Several studies showed a good correlation of 
cFFR with FFR [13, 14]. 
Aim
In our study, we sought to investigate the performance 
strength of cFFR against FFR, iFR, and a novel tool, QFR, as 
a comprehensive assessment of intermediate CAD.
Material and methods
Patients with stable CAD with angiographically am-
biguous lesions (40–90% diameter stenosis by visual as-
sessment) in a major epicardial coronary artery, who were 
scheduled for FFR, were prospectively and consecutively 
enrolled. Baseline clinical data were collected. Ethics ap-
proval was granted from the institutional ethics review 
process and all patients gave written informed consent. 
Study protocol
Coronary angiography was performed with the stan-
dard femoral or radial approach based on individual op-
erator preferences. The acquisition was done at 15 fps 
for the best image quality. The s5/s5i console and Verra-
ta Pressure Guide Wire (Philips Volcano Corporation, San 
Diego, California) were used in all cases. Data acquisition 
included an electrocardiographic signal recording. First-
ly, the pressure wire was advanced distally to the index 
lesion. After confirmation of wire position and waiting 
until the return of Pd/Pa ratio to the baseline value, cFFR 
was assessed in the following pattern. A  single rapid 
manual injection of 3 ml of radiographic contrast medi-
um through a contrast dye filled guiding catheter (+ 2 ml 
additional volume of contrast dye) (Visipaque 320, GE 
Healthcare, USA) was performed and the minimal cFFR 
value obtained was recorded (in general within the first 
10 s). Each injection of contrast medium was duplicated 
to test the reproducibility of cFFR. After any injection of 
contrast medium, flushing of the guiding catheter with 
saline was performed to avoid pressure damping due to 
contrast medium viscosity. The pressure wire was pulled 
back to the left main or ascending aorta to check for po-
tential pressure drift. Afterwards, the wire was advanced 
once again distally to the evaluated lesion and after its 
position check, saline flush of the guiding catheter and 
another 60 s of wait, iFR was calculated using fully au-
tomated algorithms in a  typical way [15]. After iFR as-
sessment, we started adenosine administration through 
a  femoral vein at a rate of 140 [µg/kg/min] for a mini-
mum of 3 min. The detailed, meticulous methodology of 
the FFR/iFR procedure was previously described [16–18]. 
The pressure wire pullback maneuver was mandatory to 
check for pressure drift. Computation of QFR was per-
formed offline, using a  software package (Medis Suite 
2.1.12.2, Medis Medical Imaging System, Leiden, the 
Netherlands) by an independent corelab analyzer blinded 
to iFR, FFR, and cFFR results [10, 19]. The analysis was 
conducted twice by each analyzer and the mean value 
(from four calculations) was used for further analysis. 
The intra- and inter-observer variability were determined 
using the intraclass correlation coefficient (ICC). The lim-
ited intra- and interobserver variability for measuring the 
QFR was confirmed by ICC of 0.991 (95% CI: 0.988–0.993) 
and 0.990 (95% CI: 0.987–0.992), respectively.
Quantitative coronary angiography (QCA) was per-
formed by an independent corelab analyzer blinded to 
the results of FFR, using the edge detection system (CAAS 
5.7 QCA system, Pie Medical). 
Statistical analysis
Categorical variables were expressed as numbers of 
patients (percentages). Continuous variables were ex-
pressed as mean ± standard deviation (SD). Non-normal-
ly distributed data were reported as median (interquar-
tile range (IQR)). The agreement among tested methods 
was assessed by the Bland-Altman plot method and ICC. 
Data are presented as the unadjusted area under the 
ROC curve (AUC) with 95% CI. All tests were 2-tailed, and 
a p-value < 0.05 was considered statistically significant. 
All statistical analyses were performed using Statistica 
13.3 (TIBCO Software Inc., Palo Alto, CA, USA).
Results
Forty-four patients with 110 intermediate coronary 
stenoses were enrolled. Patient characteristics are pre-
sented in Table I. Lesion characteristics are shown in 
Table II. Mean baseline Pd/Pa was 0.93 ±0.05. Mean 
cFFR value was similar to FFR value (0.83 ±0.09 vs. 0.81 
±0.09; p = 0.13) and QFR (0.81 ±0.1; p = 0.69) and iFR 
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(0.9 ±0.07; p = 0.10, Figure 1). A  total of 46 (41.8%) 
vessels had FFR ≤ 0.80, 50 (45.5%) vessels had cFFR 
≤ 0.83, 44 (40.0%) vessels had QFR ≤ 0.80, and 38 (34.5%) 
vessels had iFR ≤ 0.89. Resting Pd/Pa, FFR, QFR, and iFR 
were strongly correlated with cFFR (Figure 2). An excellent 
agreement between cFFR and resting Pd/Pa (ICC 0.83, 
95% CI: 0.76–0.88), FFR (ICC = 0.99, 95% CI: 0.98–0.99), 
QFR (ICC: 0.98, 95% CI: 0.97–0.98), and iFR (ICC = 0.88, 
95% CI: 0.82–0.92) was confirmed. However, cFFR showed 
stronger agreement between cFFR and FFR than be-
tween cFFR and iFR in Bland-Altman analysis (Figures 3 A 
and B). The optimal cutoff value of cFFR was 0.83 for 
prediction of FFR ≤ 0.80 with sensitivity, specificity, and 
accuracy of 96.9%, 97.8%, and 97.3% respectively. 100% 
sensitivity was observed for a cutoff value of 0.82 and 
100% specificity for a cutoff value of 0.84; AUC = 0.998 
(0.995–1.00); p < 0.001, Figure 4 A). The optimal cutoff 
value of cFFR was 0.84 for prediction of iFR ≤ 0.89 with 
sensitivity, specificity, and accuracy of 79.2%, 92.1%, and 
83.6% respectively. 100% sensitivity was observed for 
a cutoff value of 0.73 and 100% specificity for a cutoff 
value of 0.91; AUC = 0.89 (0.83–0.95); p < 0.001 (Figure 
4 B). The optimal cutoff value of baseline Pd/Pa was 0.93 
for prediction of FFR ≤ 0.80 with sensitivity, specificity, 
Table I. Study population and procedural data 
(n = 44)
Patients Value
Age [years] 66.0 ±9.8
Male sex 32 (72.7)
Height [cm] 169.8 ±8.0
Weight [kg] 79.6 ±13.5
Body mass index [kg/m2] 27.5 ±3.8
Arterial hypertension 44 (100.0)
Diabetes mellitus 22 (50.0)
Previous myocardial infarction 23 (52.3)
Previous PCI 20 (45.5)
Previous CABG 0 (0.0)
Peripheral arterial disease 1 (2.3)
Chronic obstructive pulmonary disease 0 (0.0)
Previous stroke/TIA 0 (0.0)
Hyperlipidemia 50 (100.0)
Smoking 16 (36.4)
Atrial fibrillation 1 (2.3)
Serum creatinine [μmol/l] 88.8 ±16.4
LVEF, % 52.6 ±8.5
LVEF < 40% 1 (2.3)
Heart rate [beats/min] 71.9 ±9.5












Number of assessed vessels 3.0 (2.0–4.0)
Values presented as number (percentage), mean ± standard deviation or medi-
an (interquartile range). CABG – coronary artery bypass grafting, CCS – Cana-
dian Cardiovascular Society, LVEF – left ventricle ejection fraction, NYHA – New 
York Heart Association, PCI – percutaneous coronary intervention, TIA – tran-
sient ischemic attack.








Quantitative coronary angiography results:
Lesion length [mm] 22.2 ±14.2
RVD [mm] 2.6 ±0.6
MLD [mm] 1.4 ±0.4
DS, % 44.6 ±12.0
Eccentric lesion 60 (54.5)
Moderate/severe tortuosity 44 (40.0)
Irregular contours 9 (8.2)
Moderate/severe calcifications 45 (40.9)
Ostial lesion 10 (9.1)
Values presented as number (percentage) or mean ± standard deviation. Cx – 
circumflex artery, Dg – diagonal branch, DS – diameter stenosis, LAD – left ante-
rior descending artery, Mg – marginal branch, MLD – minimal lumen diameter, 
RCA – right coronary artery, RVD – reference vessel diameter.
 Pd/Pa cFFR FFR QFR iFR
Figure 1. Mean values of resting Pd/Pa, contrast 
fractional flow reserve (cFFR) and fractional flow 
reserve (FFR), quantitative flow ratio (QFR) and in-
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and accuracy of 92.2%, 80.4%, and 87.3% respectively. 
100% sensitivity was observed for a cutoff value of 0.85 
and 100% specificity for a  cutoff value of 0.98; AUC = 
0.92 (0.87–0.97); p < 0.001. The optimal cutoff value of 
baseline Pd/Pa was 0.93 for prediction of iFR ≤ 0.89 with 
sensitivity, specificity, and accuracy of 91.7%, 94.7%, and 
92.7% respectively. 100% sensitivity was observed for 
a cutoff value of 0.91 and 100% specificity for a cutoff 
value of 0.97; AUC = 0.98 (0.95–1.00); p < 0.001.
Discussion
The results of our study showed that cFFR, calculated 
as Pd/Pa after the induction of submaximal hyperemia 
using the intracoronary bolus of standard radiographic 
contrast dye, may be accurate in predicting FFR values 
of borderline coronary lesions. Moreover, cFFR is able to 
predict the iFR values in assessing intermediate coro-
nary stenosis. Most interestingly, we found a significant 
correlation of cFFR with a novel index – QFR – which is 
calculated based on 3D-QCA and corrected TIMI frame 
count algorithms. Our results suggest that the use of the 
cut-off value of 0.82 for cFFR could be a reasonable op-
tion in patients who have contraindications to the ad-
ministration of adenosine, or the assessment of iFR is 
not possible in the cathlab.
Despite its demonstrated value in guiding coronary 
revascularization, the rate of adoption of FFR in real-world 
clinical practice remains rather low [3]. FFR assessment 
requires maximal hyperemia induced by a  vasoactive 
agent such as adenosine, which may cause some adverse 
effects during infusion or intracoronary injection (e.g. 
complete atrioventricular block, chest pain, dyspnea). 
Figure 2. cFFR comparisons. Correlation between resting Pd/Pa (A), fractional flow reserve (FFR, B), quantitative 
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r = 0.83, p < 0.001
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r = 0.81, p < 0.001
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Also, adenosine is still quite expensive. Furthermore, to 
overcome financial difficulties or side effects associated 
with the use of adenosine, a new adenosine free index 
based on measurement of the resting gradient called 
iFR was introduced. Importantly, iFR has been shown as 
non-inferior to FFR in terms of lesion severity assessment 
along with long-term clinical outcomes [7, 8]. Pd/Pa ratio 
registered by pressure wire during submaximal reactive 
hyperemia after an intracoronary bolus of contrast medi-
um may be sufficient for evaluation of the physiological 
significance of stenosis, avoiding the need of adenosine 
administration. In the RINASCI study, a strong correlation 
between cFFR and FFR values was observed (r = 0.94) 
with a  close agreement at Bland-Altman analysis (95% 
CI of disagreement: –0.029 to 0.072). ROC curve analysis 
showed excellent accuracy of the cFFR cut-off of ≤ 0.83 in 
predicting an FFR value ≤ 0.80 (AUC 0.97 (95% CI: 0.91–
0.99, specificity 96.1%, sensitivity 85.7%)) [20]. In our 
study, two lesions had a cFFR value of 0.82 and another 
two lesions had a value of 0.83, but when assessed with 
Figure 4. Receiver operating characteristic curve calculated using the threshold cut-off value of contrast frac-




































































 0.5 0.6 0.7 0.8 0.9 1.0
        Average FFR and cFFR
 0.5 0.6 0.7 0.8 0.9 1.0
        Average iFR and cFFR
 0 0.2 0.4 0.6 0.8 1.0
1-Specificity
 0.4 0.5 0.6 0.7 0.8 0.9 1.0
1-Specificity
Figure 3. Bland-Altman plots for the agreement between contrast fractional flow reserve (cFFR) and fractional 
flow reserve (FFR, A) and instantaneous wave-free ratio (iFR, B)
Bias 0.022 (95% CI limits of aggrement from –0.013 to 0.058) Bias –0.067 (95% CI limits of aggrement from –0.174 to 0.039)
AUC = 0.98 (0.995–1.00); p < 0.001 AUC = 0.89 (0.83–0.95); p < 0.001
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FFR, the lesions were classified as non-significant (FFR 
value 0.83 and 0.84, respectively). On the other hand, in 
our study cFFR ≥ 0.88 also predicted negative FFR values 
(> 0.8). In the MEMENTO–FFR study, resting Pd/Pa and 
cFFR were significantly higher than FFR (0.93 ±0.05 vs. 
0.87 ±0.08 vs. 0.84 ±0.08, respectively; p < 0.001) [21]. 
A strong correlation and a good agreement in Bland-Alt-
man analysis between cFFR and FFR were observed (r = 
0.90; and 95% CI of disagreement: from –0.042 to 0.11) 
[20]. ROC curve analysis showed excellent accuracy (89%) 
of the cFFR cut-off of ≤ 0.85 in predicting an FFR value 
≤ 0.80 (AUC 0.95 (95% CI: 0.94–0.96)), significantly bet-
ter than that observed using resting Pd/Pa (AUC = 0.90, 
95% CI: 0.88–0.91; p < 0.001) [21]. In a study by Topcu 
et al. cFFR correlated well with FFR (r = 0.89) and showed 
good agreement in Bland-Altman analysis (mean bias 
was 0.027, 95% limits for agreement from –0.038 to 
0.092) [22]. The CONTRAST study [12] compared the abil-
ity of cFFR vs. resting Pd/Pa and iFR to predict FFR. The re-
sults showed that cFFR was superior to resting Pd/Pa and 
iFR in predicting FFR while iFR and resting Pd/Pa provided 
equivalent diagnostic accuracy. In our study, the results 
clearly confirm that cFFR correlated strongly with FFR 
and QFR values. cFFR’s correlation with iFR was weaker, 
but still significant. In practice, it means that without the 
use of adenosine or any other hyperemic agent but us-
ing cFFR, a physician has a simple and always available 
tool to evalu ate the functional significance of coronary 
stenosis, much better than that which we can obtain us-
ing resting Pd/Pa. Moreover, iFR assessment is not avail-
able in every cathlab worldwide. QFR showed a  strong 
prediction ability of FFR and iFR in previous studies [9, 
10, 18, 23–26]. However, QFR is assessed offline in the 
majority of cases and requires some time for evaluation. 
In a study by Sejr-Hansen et al., the authors compared 
online and offline QFR in patients presenting with acute 
coronary syndromes, yielding similar results and good 
diagnostic performance with staged FFR as a reference, 
and a moderate diagnostic performance with staged iFR 
[27]. In our study, surprisingly, cFFR correlated well with 
QFR, even more strongly than with iFR, even though QFR 
and iFR are both non-hyperemic methods. However, this 
aspect requires further investigation, as no more data so 
far are available.
Our study has several limitations. First, the most im-
portant limitation was the small sample size. Second, 
while assessing cFFR, 3 ml of contrast medium was ad-
ministered manually instead of automatically. However, 
manual administration is more common in daily practice.
Conclusions
Contrast medium Pd/Pa ratio seems to be accurate 
in predicting the functional significance of coronary ste-
nosis assessed with FFR, iFR, and QFR. The optimal cutoff 
value of cFFR was 0.83 for prediction of FFR ≤ 0.80 and 
0.84 – for iFR ≤ 0.89.
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